Initial chemotherapy for chronic lymphocytic leukemia: what's the standard of care?

Affiliations

Comment

Matt Kalaycio. Curr Hematol Malig Rep. 2006 Mar.

. 2006 Mar;1(1):41-2.

doi: 10.1007/s11899-006-0016-5.

¹ Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA. Kalaycm@ccf.org

No abstract available

Comment on

Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia.
Keating MJ, O'Brien S, Albitar M, Lerner S, Plunkett W, Giles F, Andreeff M, Cortes J, Faderl S, Thomas D, Koller C, Wierda W, Detry MA, Lynn A, Kantarjian H. Keating MJ, et al. J Clin Oncol. 2005 Jun 20;23(18):4079-88. doi: 10.1200/JCO.2005.12.051. Epub 2005 Mar 14. J Clin Oncol. 2005. PMID: 15767648 Clinical Trial.